Sex- and gender-based personalized medicine in rheumatology

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2025-04-07 DOI:10.1038/s41584-025-01246-5

Elizabeth R. Volkmann, Carol Feghali-Bostwick

引用次数: 0

Abstract

Although autoimmune rheumatic diseases are more prevalent in women than men, few clinical trials report findings on the basis of sex and gender. Future clinical trials should report sex and gender differences in treatment and safety outcomes in a standardized manner to improve outcomes for all patients.

查看原文本刊更多论文

风湿病学中的性别和基于性别的个性化医学

虽然自身免疫性风湿病在女性中比男性更普遍，但很少有临床试验报告基于性别和性别的结果。未来的临床试验应以标准化的方式报告治疗和安全结果的性别差异，以改善所有患者的结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.